Latest Low-density lipoprotein Stories
First Positive Regulatory Agency Determination for a PCSK9 Inhibitor THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal
LONDON, May 20, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments:
Study not only confirms results from first human study but also shows even stronger effect of a KAMUT® khorasan wheat based diet in blood markers of patients suffering from ACS, especially
Both Standard and Aggressive Treatment Provide Similar Benefit in Reducing Atherosclerosis SAN DIEGO, May 7, 2015 /PRNewswire/ -- Treating both low-density lipoprotein (LDL), or "bad,"
Daily use of standardized pine bark extract found to strengthen metabolic parameters, reduce LDL cholesterol and curb oxidative stress HOBOKEN, N.J., May 6, 2015 /PRNewswire/ -- New research
First-ever meta-analysis of pitavastatin confirms no significant adverse effect compared with placebo or other statins on fasting blood glucose, HbA1c, or new-onset diabetes MONTGOMERY, Ala.,
Vitamin B5 Derivative Combined with Artichoke for Cholesterol Management* New York, NY (PRWEB) April 30, 2015 Life Extension® is offering a new
New Studies Provide More Evidence that Daily Consumption of Strawberries Can Have Positive Impact on Health WATSONVILLE, Calif., April 1, 2015 /PRNewswire-USNewswire/ -- Two new studies presented
Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
- Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date - PARIS and TARRYTOWN, N.Y., March 15,
- A woman chauffeur.
- A woman who operates an automobile.